Serina Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $51 | $5 | $56 |
Gross Profit | -6 | -20 | 22 |
EBITDA | 5,476 | -9,313 | -3,527 |
EBIT | 5,419 | -9,338 | -3,560 |
Net Income | 5,204 | -9,437 | -3,456 |
Net Change In Cash | 51 | 5 | 56 |
Free Cash Flow | -8,009 | -1,591 | -2,052 |
Cash | 6,064 | 8,706 | 345 |
Basic Shares | 10,157 | 2,790 | 1,079 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $142 | $500 | $3,039 | $54 |
Gross Profit | -29 | 355 | 2,889 | -1,227 |
EBITDA | -9,780 | -2,604 | -1,587 | -8,740 |
EBIT | -9,911 | -2,736 | -1,718 | -9,995 |
Net Income | -14,803 | -2,682 | -1,264 | -10,865 |
Net Change In Cash | 142 | 500 | 3,039 | 54 |
Free Cash Flow | -7,800 | -2,085 | -2,359 | -7,837 |
Cash | 345 | 532 | 314 | 527 |
Basic Shares | 1,079 | 1,078 | 1,077 | 1,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.13 |
2024-06-30 | $0.51 |
2024-03-31 | -$3.38 |
2023-12-31 | -$3.20 |
